Below are the most recent publications written about "Positron Emission Tomography Computed Tomography" by people in Profiles.
-
Kamaraju S, Fowler AM, Tarima S, Chaudhary LN, Burkard ME, Giever T, Cheng YC, Parkes A, Lange CA, Pipp-Dahm M, Hegeman R, Siddiqui N, Stella A, Rajguru S, Twaroski K, Zurbriggen L, Jorns JM, Rui H, Keigley QJ, Perlman SB, Salem K, Bradshaw TJ, Sahmoud T, Wisinski K. A Phase II Trial of Onapristone and Fulvestrant for Patients With ER+ and HER2- Metastatic Breast Cancer. Clin Breast Cancer. 2025 Apr; 25(3):251-260.
-
Vinogradskiy Y, Bahig H, Bucknell NW, Buchsbaum J, Shu HG. Conference Report: Review of Clinical Implementation of Advanced Quantitative Imaging Techniques for Personalized Radiotherapy. Tomography. 2024 11 14; 10(11):1798-1813.
-
Ivanidze J, Sharbatdaran A, McCalla A, Brandmaier A, Andreopoulou E, Cristofanilli M, Cigler T, Balogun OD, Magge RS, Liechty B, Karakatsanis NA, Nehmeh SA, Agee MA, Jean J, Osborne JR, Beal K, Schwartz TH, Pannullo SC, Knisely JPS, Ramakrishna R. [18F]-Fluoroestradiol (FES) brain PET in the evaluation of patients with estrogen receptor positive breast cancer and known or suspected brain metastases. Eur J Radiol. 2024 Dec; 181:111791.
-
Harrison DB, Phillips AL, Tansey JB, Clarke TJ, Wood CB, Nedzi L, Schwartz DL, Makowski L, Hayes DN, Newman G, Gleysteen JP. Brown Adipose Tissue Mimicking Head and Neck Cancer on PET Scan in a Patient on GLP-1 Drug. Laryngoscope. 2025 Feb; 135(2):741-743.
-
Chappidi MR, Iravani A, Stambler N, Baskaran S, DiPippo VA, Denes BS, Lin DW. Impact of Baseline Renal Insufficiency on Piflufolastat F-18 Performance and Investigation of Changes in Renal Function Following Piflufolastat F-18 Administration: Results From the OSPREY Trial. Clin Genitourin Cancer. 2024 Dec; 22(6):102223.
-
Kote R, Ravina M, Goyal H, Mohanty D, Gupta R, Shukla AK, Reddy M, Prasanth PN. Role of textural and radiomic analysis parameters in predicting histopathological parameters of the tumor in breast cancer patients. Nucl Med Commun. 2024 Oct 01; 45(10):835-847.
-
Furman B, Falick Michaeli T, Den R, Ben Haim S, Popovtzer A, Wygoda M, Blumenfeld P. Pelvic lymph node mapping in prostate cancer: examining the impact of PSMA PET/CT on radiotherapy decision-making in patients with node-positive disease. Cancer Imaging. 2024 Jul 29; 24(1):96.
-
Choi W, Jia Y, Kwak J, Werner-Wasik M, Dicker AP, Simone NL, Storozynsky E, Jain V, Vinogradskiy Y. Novel Functional Radiomics for Prediction of Cardiac Positron Emission Tomography Avidity in Lung Cancer Radiotherapy. JCO Clin Cancer Inform. 2024 03; 8:e2300241.
-
Blaes AH, Abu-Khalaf MM, Bender CM, Dent SF, Fung C, Smith SK, Watson S, Katta S, Merrill JK, Hudson SV. Coverage for evidence-based cancer survivorship care services. Support Care Cancer. 2024 Feb 17; 32(3):165.
-
Nussdorf A, Park E, Amigues I, Geraldino-Pardilla L, Bokhari S, Giles JT, Bathon JM. Associations of galectin-3 levels with measures of vascular disease in patients with rheumatoid arthritis. Semin Arthritis Rheum. 2024 04; 65:152357.